Skip to main content
· 2/4/2005

Massachusetts v. Mylan Laboratories

Citations

  • 357 F. Supp. 2d 314
  • 2005 U.S. Dist. LEXIS 2158
  • 2005 WL 352556

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • denying motion to dismiss unjust enrichment claim when legal remedy was available, on grounds that “[Plaintiff] may have to elect only one theory of recovery eventually, and [the Court] will not force Plaintiff to choose its remedy at this stage of the litigation”
  • to state claim for unjust enrichment under Massachusetts law, a plaintiff must plead, inter alia, the absence of a remedy provided by law
  • “Unjust enrichment does not require that a defendant receive direct payments from a plaintiff.” (citing Greenwald v. Chase Manhattan Mortgage Corp., 241 F.3d 76, 81 (1st Cir. 2001))
  • “The intended party need not be specifically or individually identified in the contract, but must fall within a class clearly intended by the parties to benefit from the contract.”
  • “The Court need not resolve these issues at this stage of the proceeding, since Massachusetts may have to elect only one theory of recovery eventually, and will not force Plaintiff to choose its remedy at this stage of the litigation.”
  • describing Medicaid as “a uniquely cooperative federal-state program”

Source: CourtListener parenthetical corpus (CC0).

Judges: Saris

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.